Cepatresic 37,5 / 325 37,5 mg, 325 mg FC tablets
PDF Leaflet Revision Date: 23 April 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Management of moderate to moderately-severe pain in adults.
Dosage (summary)
1-2 tablets every 4-6 hours as needed, max 8 tablets/day.
Special Populations
- Renal impairment
- Elderly
- Hepatic impairment
Pregnancy & Breastfeeding
Not recommended during pregnancy or breastfeeding due to potential risks.
Key Drug Interactions
- Alcohol increases sedation
- Serotonergic medicines may cause serotonin syndrome
- CYP2D6 and CYP3A4 inhibitors affect tramadol metabolism
Contraindications
- Hypersensitivity to tramadol or paracetamol
- Acute intoxication with CNS depressants
- Severe hepatic impairment
- History of seizures
Common side effects
- Nausea
- Dizziness
- Somnolence
Counselling Points
- Do not exceed recommended dose
- Avoid alcohol and CNS depressants
- Monitor for signs of overdose
Serious warnings
- Risk of respiratory depression
- Potential for dependence and withdrawal symptoms
- Serious skin reactions possible
Important Disclaimer
The Cepatresic 37,5 / 325 37,5 mg, 325 mg FC tablets professional information leaflet below is the property of Biotech Laboratories and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
